Dhampur Bio Organics Ltd(IN:DBOL)
₹146.00+2.05 (+1.42%)
IN:DBOL
Dhampur Bio Organics Ltd financials statements
₹146.00
At close:+2.05 (+1.42%)
Want to see IN:DBOL full AI Analyst Report?
Dhampur Bio Organics Ltd (DBOL) Ratios
0 Followers
Dhampur Bio Organics Ltd Ratios
IN:DBOL's free cash flow for Q1 2027 was ₹0.00. For the 2027 fiscal year, IN:DBOL's free cash flow was increased by ₹0.00 and operating cash flow was ₹0.00. See a summary of the company’s cash flow.
| Ratios | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.16 | 1.14 | 1.19 | 1.31 | 1.28 |
| Quick Ratio | 0.16 | 0.12 | 0.16 | 0.36 | 0.17 |
| Cash Ratio | 0.04 | 0.01 | 0.01 | 0.12 | 0.02 |
| Solvency Ratio | 0.06 | 0.05 | 0.07 | 0.14 | 0.12 |
| Operating Cash Flow Ratio | 0.16 | 0.12 | -0.10 | 0.41 | -0.26 |
| Short-Term Operating Cash Flow Coverage | 0.19 | 0.14 | -0.12 | 0.56 | -0.34 |
| Net Current Asset Value | ₹ -1.16B | ₹ -1.57B | ₹ -497.80M | ₹ 361.40M | ₹ 988.60M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.46 | 0.48 | 0.46 | 0.39 | 0.42 |
| Debt-to-Equity Ratio | 1.03 | 1.15 | 1.04 | 0.82 | 0.95 |
| Debt-to-Capital Ratio | 0.51 | 0.53 | 0.51 | 0.45 | 0.49 |
| Long-Term Debt-to-Capital Ratio | 0.17 | 0.19 | 0.15 | 0.15 | 0.11 |
| Financial Leverage Ratio | 2.26 | 2.37 | 2.29 | 2.10 | 2.28 |
| Debt Service Coverage Ratio | 0.16 | 0.14 | 0.15 | 0.28 | 0.22 |
| Interest Coverage Ratio | 1.14 | 5.60 | 2.04 | 4.07 | 5.25 |
| Debt to Market Cap | 1.38 | 2.61 | 1.26 | 0.85 | 0.74 |
| Interest Debt Per Share | 169.99 | 184.96 | 165.97 | 128.21 | 130.19 |
| Net Debt to EBITDA | 6.30 | 8.28 | 6.63 | 3.31 | 4.26 |
| Profitability Margins | |||||
| Gross Profit Margin | 16.06% | 25.59% | 19.82% | 22.82% | 14.13% |
| EBIT Margin | 4.92% | 4.54% | 5.92% | 7.31% | 10.22% |
| EBITDA Margin | 7.71% | 7.44% | 8.62% | 8.86% | 12.25% |
| Operating Profit Margin | 3.42% | 20.19% | 5.03% | 6.91% | 10.02% |
| Pretax Profit Margin | 1.94% | 0.84% | 3.56% | 5.60% | 8.30% |
| Net Profit Margin | 1.19% | 0.79% | 2.53% | 4.61% | 6.58% |
| Continuous Operations Profit Margin | 1.19% | 0.79% | 2.53% | 4.61% | 6.58% |
| Net Income Per EBT | 61.56% | 93.51% | 70.99% | 82.44% | 79.34% |
| EBT Per EBIT | 56.77% | 4.18% | 70.85% | 81.02% | 82.80% |
| Return on Assets (ROA) | 1.08% | 0.61% | 2.01% | 5.35% | 5.12% |
| Return on Equity (ROE) | 2.45% | 1.45% | 4.60% | 11.24% | 11.66% |
| Return on Capital Employed (ROCE) | 5.50% | 28.56% | 7.33% | 13.65% | 14.92% |
| Return on Invested Capital (ROIC) | 2.05% | 15.71% | 3.07% | 7.39% | 6.97% |
| Return on Tangible Assets | 1.08% | 0.61% | 2.01% | 5.21% | 4.98% |
| Earnings Yield | 3.28% | 3.33% | 5.62% | 11.69% | 9.17% |
| Efficiency Ratios | |||||
| Receivables Turnover | 33.07 | 29.81 | 19.03 | 14.75 | 14.10 |
| Payables Turnover | 15.39 | 12.53 | 10.75 | 11.34 | 7.91 |
| Inventory Turnover | 1.75 | 1.27 | 1.36 | 2.27 | 1.26 |
| Fixed Asset Turnover | 1.86 | 1.61 | 1.74 | 2.55 | 2.02 |
| Asset Turnover | 0.91 | 0.78 | 0.80 | 1.16 | 0.78 |
| Working Capital Turnover Ratio | 13.42 | 10.73 | 7.90 | 9.06 | 5.67 |
| Cash Conversion Cycle | 196.18 | 271.48 | 253.14 | 153.49 | 268.75 |
| Days of Sales Outstanding | 11.04 | 12.24 | 19.18 | 24.74 | 25.89 |
| Days of Inventory Outstanding | 208.86 | 288.37 | 267.92 | 160.94 | 288.99 |
| Days of Payables Outstanding | 23.72 | 29.14 | 33.96 | 32.20 | 46.13 |
| Operating Cycle | 219.90 | 300.62 | 287.11 | 185.69 | 314.88 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 24.09 | 19.49 | -15.26 | 53.43 | -37.13 |
| Free Cash Flow Per Share | 17.38 | -2.43 | -40.96 | 21.81 | -61.51 |
| Dividend Paid and CapEx Coverage Ratio | 3.02 | 0.80 | -0.52 | 1.69 | -1.52 |
| Capital Expenditure Coverage Ratio | 3.59 | 0.89 | -0.59 | 1.69 | -1.52 |
| Operating Cash Flow Coverage Ratio | 0.15 | 0.11 | -0.10 | 0.44 | -0.30 |
| Operating Cash Flow to Sales Ratio | 0.08 | 0.07 | -0.06 | 0.15 | -0.16 |
| Free Cash Flow Yield | 14.97% | -3.67% | -32.87% | 15.24% | -36.59% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 30.47 | 30.03 | 17.80 | 8.55 | 10.91 |
| Price-to-Sales (P/S) Ratio | 0.36 | 0.24 | 0.45 | 0.39 | 0.72 |
| Price-to-Book (P/B) Ratio | 0.75 | 0.44 | 0.82 | 0.96 | 1.27 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 6.68 | -27.28 | -3.04 | 6.56 | -2.73 |
| Price-to-Operating Cash Flow Ratio | 4.82 | 3.40 | -8.17 | 2.68 | -4.53 |
| Price-to-Earnings Growth (PEG) Ratio | 0.42 | -0.44 | -0.31 | 0.99 | -0.00 |
| Enterprise Value Multiple | 11.01 | 11.47 | 11.85 | 7.76 | 10.12 |
| Enterprise Value | 17.92B | 15.88B | 18.78B | 16.57B | 19.28B |
| EV to EBITDA | 11.01 | 11.47 | 11.85 | 7.76 | 10.12 |
| EV to Sales | 0.85 | 0.85 | 1.02 | 0.69 | 1.24 |
| EV to Free Cash Flow | 15.60 | -98.22 | -6.91 | 11.44 | -4.72 |
| EV to Operating Cash Flow | 11.25 | 12.26 | -18.54 | 4.67 | -7.82 |
| Tangible Book Value Per Share | 155.33 | 152.20 | 152.30 | 148.93 | 132.17 |
| Shareholders’ Equity Per Share | 155.34 | 152.21 | 152.30 | 148.93 | 132.17 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.38 | 0.06 | 0.29 | 0.18 | 0.21 |
| Revenue Per Share | 319.15 | 280.05 | 276.96 | 362.65 | 234.11 |
| Net Income Per Share | 3.81 | 2.21 | 7.00 | 16.74 | 15.41 |
| Tax Burden | 0.62 | 0.94 | 0.71 | 0.82 | 0.79 |
| Interest Burden | 0.39 | 0.19 | 0.60 | 0.77 | 0.81 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.13 | 0.02 | 0.01 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 6.32 | 8.82 | -2.18 | 2.63 | -1.91 |
Currency in INR
